CIK 0001158780
- Non-accelerated filer
- Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980351734
- Phone
- +972 747107171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Open-market sale Director sold 2,000 shares at $0.97 ($1,940)
- 4 Open-market buy Director bought 80,616 shares at $1.80 ($145,109)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 355,570 shares at an average $3.70 ($1,314,277)
- 4 Open-market sale 10% owner sold 410,376 shares at an average $3.86 ($1,584,828)
- 4 Open-market sale 10% owner sold 189,725 shares at an average $4.61 ($875,105)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 20,000 shares at $9.70 ($194,000)
- 4 Open-market buy 10% owner bought 50,000 shares at an average $9.51 ($475,500)
- 4 Open-market buy 10% owner bought 20,000 shares at $9.20 ($184,000)
- 4 Open-market buy 10% owner bought 199,129 shares at an average $10.16 ($2,024,123)
- 4 Open-market buy 10% owner bought 13,189 shares at $9.49 ($125,164)
- 4 Open-market buy 10% owner bought 34,800 shares at $9.02 ($313,896)
- 4 Open-market buy 10% owner bought 10,734 shares at an average $9.04 ($96,983)
Page 3 of 18 · 352 filings